Bone Biologics Corporation [NASDAQ: BBLG] traded at a high on 01/10/22, posting a 57.14 gain after which it closed the day’ session at $5.39. The company report on January 5, 2022 that Bone Biologics to Present at the H.C. Wainwright BioConnect Virtual Conference.
Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, today announced that Jeffrey Frelick, the Company’s president and chief executive officer, will present at the H.C. Wainwright BioConnect Virtual Conference being held January 10 – 13, 2022. A pre-recorded presentation will be available beginning Monday, January 10 at 7:00 a.m. Eastern time. Interested parties may access a webcast of the presentation on the investor relations section of the Company’s website and at this link.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
About Bone BiologicsBone Biologics was founded to pursue regenerative medicine for bone. The Company is undertaking groundbreaking work with select strategic partners, building on unprecedented research on the Nell-1 protein that has produced a significant number of studies and publications in peer reviewed scientific literature. Bone Biologics is currently focusing its development efforts for its bone graft substitute product on bone regeneration in spinal fusion and has rights to trauma and osteoporosis applications. For more information, please visit www.bonebiologics.com.
The results of the trading session contributed to over 66951519 shares changing hands. Over the past one week, the price volatility of Bone Biologics Corporation stands at 21.49% while the volatility over the past one month is 11.65%.
The market cap for BBLG stock reached $57.03 million, with 10.35 million shares outstanding and 3.09 million shares in the current float. Compared to the average trading volume of 569.08K shares, BBLG reached a trading volume of 66951519 in the most recent trading day, which is why market watchdogs consider the stock to be active.
How has BBLG stock performed recently?
Bone Biologics Corporation [BBLG] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 49.72. With this latest performance, BBLG shares gained by 37.85% in over the last four-week period, additionally sinking by -91.38% over the last 6 months .
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BBLG stock in for the last two-week period is set at 64.22, with the RSI for the last a single of trading hit 81.04, and the three-weeks RSI is set at 67.18 for Bone Biologics Corporation [BBLG]. The present Moving Average for the last 50 days of trading for this stock 3.90, while it was recorded at 3.86 for the last single week of trading.
Bone Biologics Corporation [BBLG]: Deeper insight into the fundamentals
Reflecting on the efficiency of the workforce at the company, Bone Biologics Corporation [BBLG] managed to generate an average of -$912,345 per employee.Bone Biologics Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.00 and a Current Ratio set at 0.00.